Page last updated: 2024-08-21

erythromycin and Cancer of Ovary

erythromycin has been researched along with Cancer of Ovary in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Paine, MF; Pusek, SN; Wanwimolruk, S; Watkins, PB	1
Blake, DS; Collins, JM; Jamis-Dow, CA; Klecker, RW; Pearl, ML; Watkins, PB	1
Fiorica, JV; Flannery, MT; Hoffman, MS; Love, SR; Wallach, PM	1

Trials

1 trial(s) available for erythromycin and Cancer of Ovary

Article	Year
Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4? British journal of clinical pharmacology, 2002, Volume: 54, Issue:6 Topics: Administration, Oral; Adult; Aged; Antimalarials; Area Under Curve; Breath Tests; Cross-Over Studies; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Erythromycin; Female; Humans; Liver; Male; Metabolic Clearance Rate; Middle Aged; Molecular Probes; Ovarian Neoplasms; Quinidine; Quinine; Troleandomycin	2002

Article

Year

Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4?

British journal of clinical pharmacology, 2002, Volume: 54, Issue:6

Topics: Administration, Oral; Adult; Aged; Antimalarials; Area Under Curve; Breath Tests; Cross-Over Studies; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Erythromycin; Female; Humans; Liver; Male; Metabolic Clearance Rate; Middle Aged; Molecular Probes; Ovarian Neoplasms; Quinidine; Quinine; Troleandomycin

2002

Other Studies

2 other study(ies) available for erythromycin and Cancer of Ovary

Article	Year
Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazole. American journal of clinical oncology, 1997, Volume: 20, Issue:6 Topics: Antifungal Agents; Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; Breath Tests; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Erythromycin; Female; Humans; Ketoconazole; Ovarian Neoplasms; Oxidoreductases, N-Demethylating; Paclitaxel	1997
Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity. The Journal of the Florida Medical Association, 1992, Volume: 79, Issue:12 Topics: Cisplatin; Cystadenocarcinoma; Erythromycin; Female; Hearing Loss, High-Frequency; Hearing Loss, Sensorineural; Humans; Injections, Intravenous; Middle Aged; Ovarian Neoplasms	1992

Article

Year

Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazole.

American journal of clinical oncology, 1997, Volume: 20, Issue:6

Topics: Antifungal Agents; Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; Breath Tests; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Erythromycin; Female; Humans; Ketoconazole; Ovarian Neoplasms; Oxidoreductases, N-Demethylating; Paclitaxel

1997

Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity.

The Journal of the Florida Medical Association, 1992, Volume: 79, Issue:12

Topics: Cisplatin; Cystadenocarcinoma; Erythromycin; Female; Hearing Loss, High-Frequency; Hearing Loss, Sensorineural; Humans; Injections, Intravenous; Middle Aged; Ovarian Neoplasms

1992